December 21, 2021
2 min watch
Save
VIDEO: More cancers being targeted with CAR T-cells
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
In this video, Rayne Rouce, MD, discusses the top chimeric antigen receptor T-cell therapy-related presentations at ASH, including several presentations targeting T-cell malignancies, which she said is exciting.
"We are seeing more and more cancers being targeted with CAR T-cells," Rouce, pediatric oncologist and physician scientist at Texas Children's Hospital in the Center for Cell and Gene Therapy at Baylor College of Medicine in Houston, Tex., said.
"CAR T-cells have been exciting in hematologic malignancies for a while, but really we have lagged when it comes to targeting other leukemias, lymphomas and myelomas,” she said.
Published by:
Sources/Disclosures
Collapse
Source:
Disclosures:
Rouce reports consulting for Pfizer, receiving research funding from Tessa Therapeutics, and advisory board honoraria from Novartis.
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.